|
Insider Trading: MILLENNIUM PHARMACEUTICALS INC
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of MILLENNIUM PHARMACEUTICALS INC in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of MILLENNIUM PHARMACEUTICALS INC since year 2005. Table 2 shows the detailed insider transactions of MILLENNIUM PHARMACEUTICALS INC since 2005.
The reporting company's ticker symbol is MLNM.
The reporting company's CIK number is 1002637.
The total value of stock buying since 2005 is $0.
The total value of stock sales is $20,950,822.
The total value of stock exercises is $7,775,738.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at MILLENNIUM PHARMACEUTICALS INC (MLNM) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Figure 2. Average prices of insider buys, sales, and option exercises at MILLENNIUM PHARMACEUTICALS INC (MLNM) in the past 24 months. See table 2 for insider transaction details.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for MILLENNIUM PHARMACEUTICALS INC (MLNM).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-05 | 0 | 0 | 2,041 | 50,780 | 0 | 0 |
| 2008-03 | 0 | 0 | 74,835 | 1,001,105 | 0 | 0 |
| 2008-02 | 0 | 0 | 65,104 | 896,479 | 3,561 | 28,933 |
| 2008-01 | 0 | 0 | 49,665 | 781,363 | 3,812 | 30,972 |
| 2007-12 | 0 | 0 | 276,487 | 4,269,758 | 334,134 | 3,086,209 |
| 2007-11 | 0 | 0 | 112,468 | 1,530,391 | 25,000 | 210,250 |
| 2007-10 | 0 | 0 | 96,297 | 1,056,216 | 0 | 0 |
| 2007-09 | 0 | 0 | 177,500 | 1,838,387 | 116,505 | 892,576 |
| 2007-08 | 0 | 0 | 40,000 | 399,162 | 0 | 0 |
| 2007-07 | 0 | 0 | 56,548 | 592,904 | 1,600 | 104 |
| 2007-06 | 0 | 0 | 49,500 | 512,440 | 0 | 0 |
| 2007-05 | 0 | 0 | 51,929 | 569,200 | 0 | 0 |
| 2007-04 | 0 | 0 | 38,500 | 446,272 | 8,500 | 58,480 |
| 2007-03 | 0 | 0 | 121,798 | 1,321,221 | 52,071 | 393,156 |
| 2007-02 | 0 | 0 | 110,765 | 1,246,298 | 19,787 | 166,408 |
| 2007-01 | 0 | 0 | 9,842 | 108,458 | 9,619 | 60,983 |
| 2006-12 | 0 | 0 | 0 | 0 | 18,948 | 171,056 |
| 2006-11 | 0 | 0 | 35,436 | 406,300 | 20,000 | 126,800 |
| 2006-10 | 0 | 0 | 172,500 | 2,008,162 | 112,500 | 1,099,499 |
| 2006-09 | 0 | 0 | 10,003 | 109,532 | 0 | 0 |
| 2006-08 | 0 | 0 | 177,680 | 1,806,394 | 0 | 0 |
| 2006-07 | 0 | 0 | 0 | 0 | 75,000 | 295,312 |
| 2006-05 | 0 | 0 | 0 | 0 | 80,000 | 385,000 |
| 2006-04 | 0 | 0 | 0 | 0 | 80,000 | 385,000 |
| 2006-03 | 0 | 0 | 0 | 0 | 80,000 | 385,000 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for MILLENNIUM PHARMACEUTICALS INC (MLNM)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-05-01 | Protopapas Anna (Senior Vice President) | Sale | 2,041 | 24.88 | 50,780 |
| 2008-03-11 | Keating Laurie B. (SVP and General Counsel) | Sale | 6,784 | 12.82 | 86,970 |
| 2008-03-11 | Fanucci Marsha (SVP, Chief Financial Officer) | Sale | 4,429 | 12.82 | 56,779 |
| 2008-03-07 | Protopapas Anna (Senior Vice President) | Sale | 2,010 | 13.34 | 26,812 |
| 2008-03-07 | Dunsire Deborah (President and CEO) | Sale | 14,096 | 13.34 | 188,036 |
| 2008-03-07 | Keating Laurie B. (SVP and General Counsel) | Sale | 3,216 | 13.34 | 42,900 |
| 2008-03-07 | Fanucci Marsha (SVP, Chief Financial Officer) | Sale | 5,989 | 13.34 | 79,891 |
| 2008-03-06 | Simonian Nancy A (Chief Medical Officer) | Sale | 11,729 | 13.25 | 155,409 |
| 2008-03-05 | Bolen Joseph B (Chief Scientific Officer) | Sale | 5,606 | 13.55 | 75,959 |
| 2008-03-05 | Smith Peter (Senior Vice President) | Sale | 5,773 | 13.55 | 78,221 |
| 2008-03-05 | Simonian Nancy A (Chief Medical Officer) | Sale | 5,813 | 13.55 | 78,763 |
| 2008-03-03 | Simonian Nancy A (Chief Medical Officer) | Sale | 3,150 | 13.99 | 44,068 |
| 2008-03-03 | Keating Laurie B. (SVP and General Counsel) | Sale | 6,240 | 13.99 | 87,297 |
| 2008-02-29 | Bolen Joseph B (Chief Scientific Officer) | Sale | 1,802 | 13.68 | 24,643 |
| 2008-02-29 | Simonian Nancy A (Chief Medical Officer) | Sale | 1,850 | 13.68 | 25,299 |
| 2008-02-29 | Bianchi Christophe (Executive Vice President) | Sale | 9,320 | 13.67 | 127,436 |
| 2008-02-29 | Protopapas Anna (Senior Vice President) | Sale | 4,289 | 13.67 | 58,648 |
| 2008-02-29 | Dunsire Deborah (President and CEO) | Sale | 23,820 | 13.67 | 325,663 |
| 2008-02-29 | Gansler Stephen M (Senior Vice President) | Sale | 5,794 | 13.67 | 79,222 |
| 2008-02-29 | Keating Laurie B. (SVP and General Counsel) | Sale | 4,075 | 13.67 | 55,725 |
| 2008-02-29 | Fanucci Marsha (SVP, Chief Financial Officer) | Sale | 5,480 | 13.68 | 74,940 |
| 2008-02-25 | Gansler Stephen M (Senior Vice President) | Sale | 1,650 | 13.33 | 21,994 |
| 2008-02-19 | Protopapas Anna (Senior Vice President) | Sale | 3,561 | 14.03 | 49,960 |
| 2008-02-19 | Protopapas Anna (Senior Vice President) | Option Exercise | 3,561 | 8.12 | 28,933 |
| 2008-02-04 | Bianchi Christophe (Executive Vice President) | Sale | 3,463 | 15.29 | 52,949 |
| 2008-01-18 | Protopapas Anna (Senior Vice President) | Sale | 3,812 | 16.53 | 63,012 |
| 2008-01-18 | Protopapas Anna (Senior Vice President) | Option Exercise | 3,812 | 8.12 | 30,972 |
| 2008-01-09 | Levin Mark J (Director) | Sale | 10,000 | 15.12 | 151,388 |
| 2008-01-08 | Protopapas Anna (Senior Vice President) | Sale | 1,071 | 15.23 | 16,311 |
| 2008-01-08 | Gansler Stephen M (Senior Vice President) | Sale | 1,280 | 15.23 | 19,494 |
| 2008-01-04 | Keating Laurie B. (SVP and General Counsel) | Sale | 5,281 | 14.85 | 78,422 |
| 2008-01-03 | Protopapas Anna (Senior Vice President) | Sale | 4,091 | 16.11 | 65,906 |
| 2008-01-03 | Keating Laurie B. (SVP and General Counsel) | Sale | 4,830 | 16.11 | 77,811 |
| 2008-01-02 | Levin Mark J (Director) | Sale | 10,000 | 16.17 | 161,308 |
| 2007-12-26 | Levin Mark J (Director) | Sale | 10,000 | 15.57 | 155,726 |
| 2007-12-19 | Levin Mark J (Director) | Sale | 10,000 | 14.95 | 148,729 |
| 2007-12-17 | Protopapas Anna (Senior Vice President) | Option Exercise | 143,750 | 11.51 | 1,654,562 |
| 2007-12-14 | Heidrich A Grant Iii (Director) | Sale | 25,584 | 15.42 | 394,633 |
| 2007-12-13 | Simonian Nancy A (Chief Medical Officer) | Sale | 113,063 | 15.44 | 1,745,216 |
| 2007-12-13 | Simonian Nancy A (Chief Medical Officer) | Option Exercise | 110,834 | 7.89 | 874,203 |
| 2007-12-12 | Levin Mark J (Director) | Sale | 10,000 | 15.65 | 157,189 |
| 2007-12-11 | Homcy Charles J (Director) | Sale | 59,238 | 15.81 | 936,434 |
| 2007-12-11 | Homcy Charles J (Director) | Option Exercise | 59,238 | 6.49 | 384,454 |
| 2007-12-06 | Bolen Joseph B (Chief Scientific Officer) | Sale | 20,312 | 15.18 | 308,336 |
| 2007-12-06 | Bolen Joseph B (Chief Scientific Officer) | Option Exercise | 20,312 | 8.52 | 172,990 |
| 2007-12-06 | Keating Laurie B. (SVP and General Counsel) | Sale | 1,716 | 15.18 | 26,048 |
| 2007-12-05 | Levin Mark J (Director) | Sale | 10,000 | 15.22 | 151,921 |
| 2007-12-03 | Protopapas Anna (Senior Vice President) | Sale | 5,674 | 14.55 | 82,556 |
| 2007-11-28 | Levin Mark J (Director) | Sale | 10,000 | 15.23 | 152,317 |
| 2007-11-26 | Protopapas Anna (Senior Vice President) | Sale | 5,000 | 14.32 | 71,600 |
| 2007-11-21 | Levin Mark J (Director) | Sale | 10,000 | 14.12 | 140,978 |
| 2007-11-19 | Protopapas Anna (Senior Vice President) | Sale | 5,000 | 13.62 | 68,100 |
| 2007-11-14 | Levin Mark J (Director) | Sale | 10,000 | 13.96 | 139,356 |
| 2007-11-12 | Protopapas Anna (Senior Vice President) | Sale | 5,000 | 13.41 | 67,050 |
| 2007-11-07 | Levin Mark J (Director) | Sale | 10,000 | 13.13 | 131,602 |
| 2007-11-05 | Protopapas Anna (Senior Vice President) | Sale | 5,000 | 12.62 | 63,099 |
| 2007-11-05 | Keating Laurie B. (SVP and General Counsel) | Sale | 25,000 | 12.68 | 316,875 |
| 2007-11-05 | Keating Laurie B. (SVP and General Counsel) | Option Exercise | 25,000 | 8.41 | 210,250 |
| 2007-11-01 | Protopapas Anna (Senior Vice President) | Sale | 368 | 12.00 | 4,416 |
| 2007-10-10 | Bolen Joseph B (Chief Scientific Officer) | Sale | 11,297 | 11.00 | 124,267 |
| 2007-10-10 | Kucherlapati Raju S (Director) | Sale | 75,000 | 11.06 | 829,500 |
| 2007-10-03 | Levin Mark J (Director) | Sale | 10,000 | 10.24 | 102,449 |
| 2007-09-26 | Levin Mark J (Director) | Sale | 10,000 | 10.14 | 101,424 |
| 2007-09-19 | Fanucci Marsha (SVP, Chief Financial Officer) | Sale | 7,436 | 10.67 | 79,342 |
| 2007-09-19 | Homcy Charles J (Director) | Sale | 40,000 | 10.68 | 427,236 |
| 2007-09-19 | Levin Mark J (Director) | Sale | 10,000 | 10.56 | 105,572 |
| 2007-09-18 | Fanucci Marsha (SVP, Chief Financial Officer) | Sale | 10,064 | 10.58 | 106,477 |
| 2007-09-18 | Homcy Charles J (Director) | Sale | 40,000 | 10.33 | 413,240 |
| 2007-09-18 | Homcy Charles J (Director) | Option Exercise | 60,831 | 8.44 | 513,413 |
| 2007-09-17 | Protopapas Anna (Senior Vice President) | Option Exercise | 25,674 | 4.91 | 125,964 |
| 2007-09-17 | Homcy Charles J (Director) | Sale | 10,000 | 9.76 | 97,635 |
| 2007-09-12 | Levin Mark J (Director) | Sale | 10,000 | 10.00 | 99,968 |
| 2007-09-05 | Homcy Charles J (Director) | Option Exercise | 30,000 | 8.44 | 253,199 |
| 2007-09-05 | Levin Mark J (Director) | Sale | 10,000 | 10.15 | 101,493 |
| 2007-09-04 | Homcy Charles J (Director) | Sale | 30,000 | 10.20 | 306,000 |
| 2007-08-29 | Levin Mark J (Director) | Sale | 10,000 | 9.77 | 97,711 |
| 2007-08-22 | Levin Mark J (Director) | Sale | 10,000 | 9.83 | 98,264 |
| 2007-08-15 | Levin Mark J (Director) | Sale | 10,000 | 10.23 | 102,283 |
| 2007-08-01 | Levin Mark J (Director) | Sale | 10,000 | 10.09 | 100,904 |
| 2007-07-31 | Heidrich A Grant Iii (Director) | Sale | 1,600 | 10.12 | 16,191 |
| 2007-07-31 | Heidrich A Grant Iii (Director) | Option Exercise | 1,600 | .06 | 104 |
| 2007-07-30 | Smith Peter (Senior Vice President) | Sale | 11,284 | 10.11 | 114,081 |
| 2007-07-19 | Dunsire Deborah (President and CEO) | Sale | 33,664 | 10.61 | 357,175 |
| 2007-07-11 | Levin Mark J (Director) | Sale | 10,000 | 10.55 | 105,457 |
| 2007-06-27 | Levin Mark J (Director) | Sale | 10,000 | 10.33 | 102,676 |
| 2007-06-20 | Levin Mark J (Director) | Sale | 10,000 | 10.44 | 104,400 |
| 2007-06-13 | Levin Mark J (Director) | Sale | 10,000 | 10.33 | 103,266 |
| 2007-06-06 | Levin Mark J (Director) | Sale | 10,000 | 10.46 | 104,625 |
| 2007-05-30 | Levin Mark J (Director) | Sale | 10,000 | 10.75 | 107,500 |
| 2007-05-23 | Levin Mark J (Director) | Sale | 10,000 | 10.84 | 108,446 |
| 2007-05-16 | Levin Mark J (Director) | Sale | 10,000 | 10.93 | 109,305 |
| 2007-05-09 | Levin Mark J (Director) | Sale | 10,000 | 11.11 | 111,061 |
| 2007-05-02 | Levin Mark J (Director) | Sale | 10,000 | 11.15 | 111,534 |
| 2007-05-01 | Protopapas Anna (Senior Vice President) | Sale | 1,929 | 11.07 | 21,354 |
| 2007-04-18 | Levin Mark J (Director) | Sale | 10,000 | 12.00 | 119,995 |
| 2007-04-11 | Levin Mark J (Director) | Sale | 10,000 | 11.45 | 114,504 |
| 2007-04-09 | Protopapas Anna (Senior Vice President) | Sale | 4,250 | 11.56 | 49,130 |
| 2007-04-09 | Protopapas Anna (Senior Vice President) | Option Exercise | 4,250 | 6.88 | 29,240 |
| 2007-04-04 | Levin Mark J (Director) | Sale | 10,000 | 11.42 | 114,193 |
| 2007-04-02 | Protopapas Anna (Senior Vice President) | Sale | 4,250 | 11.40 | 48,450 |
| 2007-04-02 | Protopapas Anna (Senior Vice President) | Option Exercise | 4,250 | 6.88 | 29,240 |
| 2007-03-28 | Levin Mark J (Director) | Sale | 10,000 | 11.33 | 113,306 |
| 2007-03-26 | Protopapas Anna (Senior Vice President) | Sale | 8,500 | 11.38 | 96,730 |
| 2007-03-26 | Protopapas Anna (Senior Vice President) | Option Exercise | 8,500 | 6.88 | 58,480 |
| 2007-03-21 | Levin Mark J (Director) | Sale | 10,000 | 10.92 | 109,170 |
| 2007-03-20 | Keating Laurie B. (SVP and General Counsel) | Sale | 12,400 | 11.00 | 136,400 |
| 2007-03-20 | Keating Laurie B. (SVP and General Counsel) | Option Exercise | 12,400 | 8.41 | 104,284 |
| 2007-03-19 | Protopapas Anna (Senior Vice President) | Sale | 4,088 | 10.73 | 43,864 |
| 2007-03-19 | Protopapas Anna (Senior Vice President) | Option Exercise | 4,088 | 7.99 | 32,663 |
| 2007-03-14 | Levin Mark J (Director) | Sale | 10,000 | 10.68 | 106,752 |
| 2007-03-13 | Keating Laurie B. (SVP and General Counsel) | Sale | 25,568 | 10.92 | 279,100 |
| 2007-03-13 | Keating Laurie B. (SVP and General Counsel) | Option Exercise | 19,000 | 8.41 | 159,790 |
| 2007-03-12 | Protopapas Anna (Senior Vice President) | Sale | 1,970 | 10.64 | 20,960 |
| 2007-03-12 | Fanucci Marsha (SVP, Chief Financial Officer) | Sale | 4,245 | 10.64 | 45,166 |
| 2007-03-09 | Protopapas Anna (Senior Vice President) | Sale | 3,833 | 10.59 | 40,572 |
| 2007-03-09 | Protopapas Anna (Senior Vice President) | Option Exercise | 3,833 | 2.27 | 8,699 |
| 2007-03-08 | Dunsire Deborah (President and CEO) | Sale | 10,771 | 10.41 | 112,126 |
| 2007-03-08 | Fanucci Marsha (SVP, Chief Financial Officer) | Sale | 6,173 | 10.41 | 64,260 |
| 2007-03-07 | Levin Mark J (Director) | Sale | 10,000 | 10.44 | 104,450 |
| 2007-02-21 | Levin Mark J (Director) | Sale | 10,000 | 11.14 | 111,361 |
| 2007-02-16 | Homcy Charles J (Director) | Sale | 27,774 | 11.24 | 312,179 |
| 2007-02-14 | Levin Mark J (Director) | Sale | 10,000 | 11.13 | 111,341 |
| 2007-02-12 | Keating Laurie B. (SVP and General Counsel) | Sale | 29,469 | 11.29 | 332,632 |
| 2007-02-12 | Keating Laurie B. (SVP and General Counsel) | Option Exercise | 19,787 | 8.41 | 166,408 |
| 2007-02-12 | Tepper Robert I (President, R&D) | Sale | 22,500 | 11.36 | 255,600 |
| 2007-02-06 | Fanucci Marsha (SVP, Chief Financial Officer) | Sale | 7,497 | 11.17 | 83,741 |
| 2007-02-02 | Bianchi Christophe (Executive Vice President) | Sale | 3,525 | 11.19 | 39,444 |
| 2007-01-24 | Homcy Charles J (Director) | Option Exercise | 2,394 | 6.34 | 15,177 |
| 2007-01-23 | Homcy Charles J (Director) | Option Exercise | 7,225 | 6.34 | 45,806 |
| 2007-01-04 | Protopapas Anna (Senior Vice President) | Sale | 4,524 | 11.02 | 49,854 |
| 2007-01-04 | Keating Laurie B. (SVP and General Counsel) | Sale | 5,318 | 11.02 | 58,604 |
| 2006-12-14 | Wild Anthony H (Director) | Option Exercise | 8,948 | 9.67 | 86,556 |
| 2006-12-04 | Friel Robert F (Director) | Option Exercise | 10,000 | 8.45 | 84,500 |
| 2006-11-21 | Homcy Charles J (Director) | Sale | 20,000 | 11.44 | 228,800 |
| 2006-11-21 | Homcy Charles J (Director) | Option Exercise | 20,000 | 6.34 | 126,800 |
| 2006-11-20 | Tepper Robert I (President, R&D) | Sale | 15,000 | 11.50 | 172,425 |
| 2006-11-01 | Protopapas Anna (Senior Vice President) | Sale | 436 | 11.64 | 5,075 |
| 2006-10-30 | Tepper Robert I (President, R&D) | Sale | 60,000 | 11.88 | 712,725 |
| 2006-10-27 | Dunsire Deborah (President and CEO) | Sale | 112,500 | 11.52 | 1,295,437 |
| 2006-10-27 | Dunsire Deborah (President and CEO) | Option Exercise | 112,500 | 9.77 | 1,099,499 |
| 2006-09-18 | Fanucci Marsha (SVP, Chief Financial Officer) | Sale | 10,003 | 10.95 | 109,532 |
| 2006-08-17 | Heidrich A Grant Iii (Director) | Sale | 95,980 | 10.42 | 1,000,015 |
| 2006-08-14 | Heidrich A Grant Iii (Director) | Sale | 71,300 | 9.87 | 703,731 |
| 2006-08-10 | Heidrich A Grant Iii (Director) | Sale | 7,000 | 9.87 | 69,090 |
| 2006-08-09 | Tepper Robert I (President, R&D) | Sale | 1,700 | 9.87 | 16,779 |
| 2006-08-09 | Heidrich A Grant Iii (Director) | Sale | 1,700 | 9.87 | 16,779 |
| 2006-07-31 | Tepper Robert I (President, R&D) | Option Exercise | 75,000 | 3.94 | 295,312 |
| 2006-05-02 | Lander Eric S (Director) | Option Exercise | 80,000 | 4.81 | 385,000 |
| 2006-04-24 | Heidrich A Grant Iii (Director) | Option Exercise | 80,000 | 4.81 | 385,000 |
| 2006-03-20 | Kucherlapati Raju S (Director) | Option Exercise | 80,000 | 4.81 | 385,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of MILLENNIUM PHARMACEUTICALS INC (symbol MLNM,
CIK number 1002637) see
the Securities and Exchange Commission (SEC) website.
|
|
